Find Triptorelin Pamoate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0INTERMEDIATES

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 57773-63-4, Triptoreline, Arvekap, (d-trp6)-gnrh, Decapeptyl, Triptorelina
Molecular Formula
C64H82N18O13
Molecular Weight
1311.4  g/mol
InChI Key
VXKHXGOKWPXYNA-PGBVPBMZSA-N

Triptorelin Pamoate
A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE with D-tryptophan substitution at residue 6.
1 2D Structure

Triptorelin Pamoate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
2.1.2 InChI
InChI=1S/C64H82N18O13/c1-34(2)23-46(56(88)75-45(13-7-21-69-64(66)67)63(95)82-22-8-14-52(82)62(94)72-31-53(65)85)76-58(90)48(25-36-28-70-42-11-5-3-9-40(36)42)78-57(89)47(24-35-15-17-39(84)18-16-35)77-61(93)51(32-83)81-59(91)49(26-37-29-71-43-12-6-4-10-41(37)43)79-60(92)50(27-38-30-68-33-73-38)80-55(87)44-19-20-54(86)74-44/h3-6,9-12,15-18,28-30,33-34,44-52,70-71,83-84H,7-8,13-14,19-27,31-32H2,1-2H3,(H2,65,85)(H,68,73)(H,72,94)(H,74,86)(H,75,88)(H,76,90)(H,77,93)(H,78,89)(H,79,92)(H,80,87)(H,81,91)(H4,66,67,69)/t44-,45-,46-,47-,48+,49-,50-,51-,52-/m0/s1
2.1.3 InChI Key
VXKHXGOKWPXYNA-PGBVPBMZSA-N
2.1.4 Canonical SMILES
CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8
2.1.5 Isomeric SMILES
CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 6-d-tryptophan-luteinizing Hormone-releasing Factor (pig)

2. Ay 25650

3. Ay-25650

4. Ay25650

5. Cl 118532

6. Cl-118532

7. Cl118532

8. D-trp-6-lh-rh

9. Decapeptyl

10. Decapeptyl Depot

11. Decapeptyl Lp

12. Decapeptyl Trimestral

13. Embonate, Triptorelin

14. Gnrh, Trp(6)-

15. Lhrh, Trp(6)-

16. Lhrh, Tryptophyl(6)-

17. Pamoate, Triptorelin

18. Trelstar

19. Trimestral, Decapeptyl

20. Triptorelin Embonate

21. Triptorelin Pamoate

22. Wy 42462

23. Wy-42462

24. Wy42462

2.2.2 Depositor-Supplied Synonyms

1. 57773-63-4

2. Triptoreline

3. Arvekap

4. (d-trp6)-gnrh

5. Decapeptyl

6. Triptorelina

7. Triptorelinum

8. Trelstar

9. Triptodur

10. Diphereline

11. (6-d-tryptophan)luteinizing Hormone-releasing Hormone

12. Cl 118532

13. Cl-118532

14. Pglu-his-trp-ser-tyr-d-trp-leu-arg-pro-gly-nh2

15. Ay-25650

16. Luteinizing Hormone-releasing Factor (pig), 6-d-tryptophan

17. Cl 118,532

18. Chebi:63633

19. Wy 42462

20. Ay 25650

21. Pamorelin

22. Salvacyl

23. Trelstar Depot

24. 5-oxo-l-prolyl-l-histidyl-l-tryptophyl-l-seryl-l-tyrosyl-d-tryptophyl-l-leucyl-l-arginyl-l-prolylglycinamide

25. Trelstar La

26. Luteinizing Hormone-releasing Factor (swine), 6-d-tryptophan-

27. Bim 21003

28. Wy 42422

29. Tryptorelin

30. Diferelin

31. D-tryptophan-lh-rh

32. Triptoreline [inn-french]

33. Triptorelinum [inn-latin]

34. Triptorelina [inn-spanish]

35. Trellasar

36. Moapar

37. Triptorelin [usan:inn:ban]

38. Decapeptyl Sr

39. Pamorelin La

40. Unii-9081y98w2v

41. Triptorelin (swine)

42. Wy-42462

43. D-trp6-lhrh

44. Debio-8206

45. Triptorelin (usan/inn)

46. (d-trp6)-lh-rh

47. Gtpl1177

48. Schembl5079698

49. Chembl1201334

50. Dtxsid2048375

51. Schembl22289009

52. Hms2090c17

53. Ex-a3857

54. Bim-21003

55. Akos030213249

56. 9081y98w2v

57. Cs-5745

58. Db06825

59. Ncgc00167301-01

60. Ncgc00167301-02

61. As-71149

62. Bn-52014

63. Hy-12551

64. 73t634

65. C75704

66. D06247

67. [d-trp6]-lh-rh, >=97% (hplc), Powder

68. Ab01275488-01

69. A936467

70. Pglu-his-trp-ser-tyr-d-trp-leu-arg-pro-glynh2

71. Q1992452

72. (s)-1-((3s,6s,9s,12s,15r,18s,21s)-3-((1h-imidazol-5-yl)methyl)-6,15-bis((1h-indol-3-yl)methyl)-21-(3-guanidinopropyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-18-isobutyl-1,4,7,10,13,16,19-heptaoxo-1-((s)-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaazadocosan-22-oyl)-n-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide

73. Glycinamide, 5-oxo-l-prolyl-l-histidyl-l-tryptophyl-l-seryl-l-tyrosyl-d-tryptophyl-l-leucyl-l-arginyl-l-prolyl-

2.3 Create Date
2008-12-10
3 Chemical and Physical Properties
Molecular Weight 1311.4 g/mol
Molecular Formula C64H82N18O13
XLogP3-0.3
Hydrogen Bond Donor Count17
Hydrogen Bond Acceptor Count15
Rotatable Bond Count33
Exact Mass1310.63087474 g/mol
Monoisotopic Mass1310.63087474 g/mol
Topological Polar Surface Area490 Ų
Heavy Atom Count95
Formal Charge0
Complexity2710
Isotope Atom Count0
Defined Atom Stereocenter Count9
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameTrelstar
PubMed HealthTriptorelin (Injection)
Drug ClassesAntineoplastic Agent, Endocrine-Metabolic Agent
Drug LabelTRELSTAR is a white to slightly yellow lyophilized cake. When reconstituted, TRELSTAR has a milky appearance. It contains a pamoate salt of triptorelin, a synthetic decapeptide agonist analog of gonadotropin releasing hormone (GnRH). The chemical...
Active IngredientTriptorelin pamoate
Dosage FormInjectable
RouteIntramuscular
Strengtheq 11.25mg base/vial; eq 3.75mg base/vial; eq 22.5mg base/vial
Market StatusPrescription
CompanyWatson Labs

2 of 2  
Drug NameTrelstar
PubMed HealthTriptorelin (Injection)
Drug ClassesAntineoplastic Agent, Endocrine-Metabolic Agent
Drug LabelTRELSTAR is a white to slightly yellow lyophilized cake. When reconstituted, TRELSTAR has a milky appearance. It contains a pamoate salt of triptorelin, a synthetic decapeptide agonist analog of gonadotropin releasing hormone (GnRH). The chemical...
Active IngredientTriptorelin pamoate
Dosage FormInjectable
RouteIntramuscular
Strengtheq 11.25mg base/vial; eq 3.75mg base/vial; eq 22.5mg base/vial
Market StatusPrescription
CompanyWatson Labs

4.2 Drug Indication

Triptorelin is indicated for the palliative treatment of advanced prostate cancer.


FDA Label


For the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.


5 Pharmacology and Biochemistry
5.1 Pharmacology

The first administration of triptorelin is followed by a transient surge of follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol,and testosterone. The time, peak and decline of testosterone in the body varies depending on the dose administered. This initial surge is often responsible for worsening of prostate cancer symptoms such as urethral or bladder outlet obstruction, bone pain, spinal cord injury and hematuria in the early stages. A sustained decrease in FSH and LH, and significant reduction of testicular steroidogenesis is usually seen 2-4 weeks post-initiation of therapy. This result is a reduction of serum testosterone to levels which are typically seen in surgically castrated men. Ultimately, tissues and functions that require these hormones become inactive. The effects of triptorelin can usually be reversed once the drug is discontinued.


5.2 MeSH Pharmacological Classification

Antineoplastic Agents, Hormonal

Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)


Luteolytic Agents

Chemical compounds that cause LUTEOLYSIS or degeneration of the CORPUS LUTEUM. (See all compounds classified as Luteolytic Agents.)


5.3 ATC Code

QH01CA97


L - Antineoplastic and immunomodulating agents

L02 - Endocrine therapy

L02A - Hormones and related agents

L02AE - Gonadotropin releasing hormone analogues

L02AE04 - Triptorelin


5.4 Absorption, Distribution and Excretion

Absorption

Following IV administration of triptorelin, triptorelin is completely absorbed.


Route of Elimination

Elimination of triptorelin involves both the kidneys and the liver.


Volume of Distribution

After a single IV dose of 0.5mg, the volume of distribution of triptorelin peptide in healthy males was 30 - 33L.


Clearance

In healthy male volunteers, total clearance of triptorelin was 211.9 mL/min.


5.5 Metabolism/Metabolites

The metabolism of triptorelin in humans is not well understood; however, metabolism likely does not involve hepatic enzymes such as cytochrome P450. Whether or not triptorelin affects, or how it affects other metabolizing enzymes is also poorly understood. Triptorelin has no identified metabolites.


5.6 Biological Half-Life

The pharmacokinetics of triptorelin follows a 3 compartment model. The half lives are estimated to be 6 minutes, 45 minutes, and 3 hours respectively.


5.7 Mechanism of Action

Triptorelin is a synthetic agonist analog of gonadotropin releasing hormone (GnRH). Animal studies comparing triptorelin to native GnRH found that triptorelin had 13 fold higher releasing activity for luteinizing hormone, and 21-fold higher releasing activity for follicle-stimulating hormone.


API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"TRIPTORELIN ACETATE","year":"2021","qtr":"Q2","strtotime":1618252200,"product":"TRIPTORELIN ACETATE","address":"","city":"","supplier":"CIP GLOBAL CO., LTD","supplierCountry":"CHINA","foreign_port":"NANJING","customer":"BIOZENTA LIFESCIENCE PRIVATE ","customerCountry":"INDIA","quantity":"0.09","actualQuantity":"85","unit":"GMS","unitRateFc":"109","totalValueFC":"9227.8","currency":"USD","unitRateINR":"8082.4","date":"13-Apr-2021","totalValueINR":"686999.75","totalValueInUsd":"9227.8","indian_port":"DELHI AIR","hs_no":"29371900","bill_no":"3551366","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NANJING","supplierAddress":"","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1686162600,"product":"TRIPTORELIN PAMOATE","address":"VILLAGE NAG KALAN,MAJITHA ROAD,MAJ ITHA","city":"AMRITSAR,PUNJAB","supplier":"HIGHPHARM MEDCHEM CO.LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"KWALITY PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"29.997","unit":"GMS","unitRateFc":"600","totalValueFC":"18261.8","currency":"USD","unitRateINR":"50040","date":"08-Jun-2023","totalValueINR":"1501050.173","totalValueInUsd":"18261.8","indian_port":"DELHI AIR","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"VILLAGE NAG KALAN,MAJITHA ROAD,MAJ ITHA"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1728066600,"product":"TRIPTORELIN PAMOATE","address":"VILLAGE NAG KALAN,MAJITHA ROAD,MAJ","city":"AMRITSAR,PUNJAB","supplier":"BACHEM AG","supplierCountry":"SWITZERLAND","foreign_port":"BASEL\/MULHOUSE","customer":"KWALITY PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.02","actualQuantity":"15","unit":"GMS","unitRateFc":"780","totalValueFC":"13783.8","currency":"USD","unitRateINR":"77213.5","date":"05-Oct-2024","totalValueINR":"1158202.5","totalValueInUsd":"13783.8","indian_port":"Delhi Air","hs_no":"29339990","bill_no":"5967856","productDescription":"API","marketType":"REGULATED MARKET","country":"SWITZERLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"BASEL\/MULHOUSE","supplierAddress":"HAUPTSTRASSE 144 CH-4416 BUBENDORF SDNF SDNF","customerAddress":"VILLAGE NAG KALAN,MAJITHA ROAD,MAJ"}]
13-Apr-2021
05-Oct-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Europe

read-more
read-more

01

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Triptorelinum

Brand Name : Pamorelin LA

Dosage Form : Trockensub

Dosage Strength : 22.5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Triptorelinum

Brand Name : Salvacyl

Dosage Form : Trockensub

Dosage Strength : 11.25mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

IPSEN SpA

France
BIO Partnering at JPM
Not Confirmed
arrow

IPSEN SpA

France
arrow
BIO Partnering at JPM
Not Confirmed

Triptorelin

Brand Name : Decapeptyl

Dosage Form : Tryptoreline 11,25Mg 1 Unit Parenteral Use

Dosage Strength : 1 vial IM 11.25 mg + 1 ampoule solv 2 ml + 1 syringe

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

04

IPSEN SpA

France
Biotech Showcase
Not Confirmed
arrow

IPSEN SpA

France
arrow
Biotech Showcase
Not Confirmed

Triptorelin

Brand Name : Decapeptyl

Dosage Form :

Dosage Strength : 7 Vials 0.1 Mg + 7 Vials Solv  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

Laboratoires Sodia

Country
BIO Partnering at JPM
Not Confirmed
arrow

Laboratoires Sodia

Country
arrow
BIO Partnering at JPM
Not Confirmed

triptorelinembonat

Brand Name : Moapar

Dosage Form : PULVER OCH VÄTSKA TILL INJEKTIONSVÄTSKA

Dosage Strength : 11,25 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

06

Institute Produits Synthèse

Country
BIO Partnering at JPM
Not Confirmed
arrow

Institute Produits Synthèse

Country
arrow
BIO Partnering at JPM
Not Confirmed

triptorelinembonat

Brand Name : Pamorelin

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : 11.25 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

07

Institute Produits Synthèse

Country
BIO Partnering at JPM
Not Confirmed
arrow

Institute Produits Synthèse

Country
arrow
BIO Partnering at JPM
Not Confirmed

triptorelinembonat

Brand Name : Pamorelin

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : 22.5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

08

Institute Produits Synthèse

Country
BIO Partnering at JPM
Not Confirmed
arrow

Institute Produits Synthèse

Country
arrow
BIO Partnering at JPM
Not Confirmed

triptorelinembonat

Brand Name : Pamorelin

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : 3.75 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

09

Institut Produits Synthèse (IPSEN) AB

Country
BIO Partnering at JPM
Not Confirmed
arrow

Institut Produits Synthèse (IPSEN) AB

Country
arrow
BIO Partnering at JPM
Not Confirmed

Triptorelin

Brand Name : Pamorelin

Dosage Form : Powder and liquid to depot injection fluid, suspension

Dosage Strength : 22.5 mg

Packaging : Set

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

10

Institut Produits Synthèse (IPSEN) AB

Country
BIO Partnering at JPM
Not Confirmed
arrow

Institut Produits Synthèse (IPSEN) AB

Country
arrow
BIO Partnering at JPM
Not Confirmed

Triptorelin

Brand Name : Pamorelin

Dosage Form : Powder and liquid to depot injection fluid, suspension

Dosage Strength : 3.75 mg

Packaging : Set

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 3.75MG...DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 3.75MG BASE/VIAL

USFDA APPLICATION NUMBER - 20715

read-more

DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 11.25M...DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 11.25MG BASE/VIAL

USFDA APPLICATION NUMBER - 21288

read-more

DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 22.5MG...DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 22.5MG BASE/VIAL

USFDA APPLICATION NUMBER - 22437

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Solubilizers

read-more
read-more

Direct Compression

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Parenteral

read-more
read-more

Taste Masking

read-more
read-more

Rheology Modifiers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Topical

read-more
read-more

Emulsifying Agents

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Granulation

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Coating Systems & Additives

read-more
read-more

API Stability Enhancers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Moapar Manufacturers

A Moapar manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Moapar, including repackagers and relabelers. The FDA regulates Moapar manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Moapar API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Moapar manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Moapar Suppliers

A Moapar supplier is an individual or a company that provides Moapar active pharmaceutical ingredient (API) or Moapar finished formulations upon request. The Moapar suppliers may include Moapar API manufacturers, exporters, distributors and traders.

click here to find a list of Moapar suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Moapar USDMF

A Moapar DMF (Drug Master File) is a document detailing the whole manufacturing process of Moapar active pharmaceutical ingredient (API) in detail. Different forms of Moapar DMFs exist exist since differing nations have different regulations, such as Moapar USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Moapar DMF submitted to regulatory agencies in the US is known as a USDMF. Moapar USDMF includes data on Moapar's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Moapar USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Moapar suppliers with USDMF on PharmaCompass.

Moapar WC

A Moapar written confirmation (Moapar WC) is an official document issued by a regulatory agency to a Moapar manufacturer, verifying that the manufacturing facility of a Moapar active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Moapar APIs or Moapar finished pharmaceutical products to another nation, regulatory agencies frequently require a Moapar WC (written confirmation) as part of the regulatory process.

click here to find a list of Moapar suppliers with Written Confirmation (WC) on PharmaCompass.

Moapar NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Moapar as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Moapar API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Moapar as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Moapar and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Moapar NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Moapar suppliers with NDC on PharmaCompass.

Moapar GMP

Moapar Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Moapar GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Moapar GMP manufacturer or Moapar GMP API supplier for your needs.

Moapar CoA

A Moapar CoA (Certificate of Analysis) is a formal document that attests to Moapar's compliance with Moapar specifications and serves as a tool for batch-level quality control.

Moapar CoA mostly includes findings from lab analyses of a specific batch. For each Moapar CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Moapar may be tested according to a variety of international standards, such as European Pharmacopoeia (Moapar EP), Moapar JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Moapar USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty